BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36749566)

  • 1. Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19.
    Infante M; Pieri M; Lupisella S; Mohamad A; Bernardini S; Della-Morte D; Fabbri A; De Stefano A; Iannetta M; Ansaldo L; Crea A; Andreoni M; Morello M
    Curr Med Res Opin; 2023 Apr; 39(4):505-516. PubMed ID: 36749566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.
    Infante M; Buoso A; Pieri M; Lupisella S; Nuccetelli M; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Colizzi V; Morello M
    J Am Nutr Assoc; 2022; 41(3):250-265. PubMed ID: 33600292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19.
    Infante M; Pieri M; Lupisella S; D'Amore L; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Morello M
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):5889-5903. PubMed ID: 34661247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early reduction of estimated Glomerular Filtration Rate (eGFR) predicts poor outcome in acutely ill hospitalized COVID-19 patients firstly admitted to medical regular wards (eGFR-COV19 study).
    Cei F; Chiarugi L; Brancati S; Montini MS; Dolenti S; Di Stefano D; Beatrice S; Sellerio I; Messiniti V; Gucci MM; Vannini G; Lavecchia R; Cioni E; Mattaliano C; Pelagalli G; Panigada G; Murgo E; Mazzoccoli G; Landini G; Tarquini R
    Biomed Pharmacother; 2022 Sep; 153():113454. PubMed ID: 36076568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between COVID-19 Outcomes and Patient Characteristics: A Study in an Inner-City Community Hospital.
    Almonte M; Au XY; Ali M; Rajabalee N; Hasan S; Shibre T; Li Y; Kaplan AC
    Cureus; 2021 Aug; 13(8):e17255. PubMed ID: 34540480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes.
    Chen X; Chen Y; Wu C; Wei M; Xu J; Chao YC; Song J; Hou D; Zhang Y; Du C; Li X; Song Y
    BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33214191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia).
    Sonmez A; Demirci I; Haymana C; Tasci I; Dagdelen S; Salman S; Ata N; Sahin I; Emral R; Cakal E; Atmaca A; Sahin M; Celik O; Demir T; Ertugrul D; Unluturk U; Caglayan M; Satman I
    J Diabetes; 2021 Jul; 13(7):585-595. PubMed ID: 33655669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry.
    Uribarri A; Núñez-Gil IJ; Aparisi A; Becerra-Muñoz VM; Feltes G; Trabattoni D; Fernández-Rozas I; Viana-Llamas MC; Pepe M; Cerrato E; Capel-Astrua T; Romero R; Castro-Mejía AF; El-Battrawy I; López-País J; D'Ascenzo F; Fabregat-Andres O; Bardají A; Raposeiras-Roubin S; Marín F; Fernández-Ortiz A; Macaya C; Estrada V;
    J Nephrol; 2020 Aug; 33(4):737-745. PubMed ID: 32602006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
    Ouyang SM; Zhu HQ; Xie YN; Zou ZS; Zuo HM; Rao YW; Liu XY; Zhong B; Chen X
    BMC Infect Dis; 2020 Dec; 20(1):952. PubMed ID: 33308159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.
    Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J
    Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy.
    Mirani M; Favacchio G; Carrone F; Betella N; Biamonte E; Morenghi E; Mazziotti G; Lania AG
    Diabetes Care; 2020 Dec; 43(12):3042-3049. PubMed ID: 33023989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.
    Zahid U; Ramachandran P; Spitalewitz S; Alasadi L; Chakraborti A; Azhar M; Mikhalina G; Sherazi A; Narh JT; Khattar P; Bedi P
    Am J Nephrol; 2020; 51(10):786-796. PubMed ID: 33011717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia.
    Abolfotouh MA; Musattat A; Alanazi M; Alghnam S; Bosaeed M
    BMC Infect Dis; 2022 Dec; 22(1):950. PubMed ID: 36526994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections.
    Budweiser S; Baş Ş; Jörres RA; Engelhardt S; von Delius S; Lenherr K; Deerberg-Wittram J; Bauer A
    Respir Res; 2021 Jun; 22(1):168. PubMed ID: 34098967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in glomerular filtration rate and metabolomic differences in severely ill coronavirus disease survivors 3 months after discharge.
    Zhou M; Tan X; Luo P; Xu J; Yin Z; Liao T; Wang S; Wang Z; Jin Y
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166289. PubMed ID: 34656797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated with Length of Hospitalization in Patients with Diabetes and Mild COVID-19: Experiences from a Tertiary University Center in Serbia.
    Ciric VM; Rancic NK; Pesic MM; Radojkovic DB; Milenkovic N
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792970
    [No Abstract]   [Full Text] [Related]  

  • 19. Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England.
    Heald AH; Jenkins DA; Williams R; Mudaliar RN; Khan A; Syed A; Sattar N; Khunti K; Naseem A; Bowden-Davies KA; Gibson JM; Ollier W;
    Diabetes Ther; 2023 Dec; 14(12):2031-2042. PubMed ID: 37620452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis.
    Heald AH; Jenkins DA; Williams R; Sperrin M; Fachim H; Mudaliar RN; Syed A; Naseem A; Gibson JM; Bowden Davies KA; Peek N; Anderson SG; Peng Y; Ollier W
    Diabetes Ther; 2022 May; 13(5):1007-1021. PubMed ID: 35325361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.